# ARTL (Artelo Biosciences, Inc.) - SEC EDGAR Financial Statements

> Artelo Biosciences, Inc. reported $6.67M in total assets and a net loss of $11.32M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ARTL
- Markdown: https://convexityos.com/fundamentals/ARTL.md
- SEC CIK: 0001621221
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001621221&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$9.77M | Operating profit |
| Net Income | FY 2025 | -$11.32M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$20.42 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $4.2K | Total debt: $40K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.42M | $5.99M | $5.70M | $4.32M | $3.78M | $2.84M | $1.92M | $1.09M | $1.25M | -- |
| Total Operating Expenses | $11.40M | $10.11M | $9.93M | $10.29M | $9.42M | $7.44M | $4.69M | $3.21M | $2.34M | $233K |
| **Operating Income** | -$11.40M | -$10.11M | -$9.93M | -$10.29M | -$9.42M | -$7.44M | -$4.69M | -$3.21M | -$2.34M | -$233K |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -$4.69M | -$3.21M | -$2.34M | -- |
| Interest Expense | $194K | $0 | $0 | $5.0K | -- | $0 | -- | -- | -- | $2.1K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$12.88M | -$9.83M | -$9.29M | -$10.08M | -$9.41M | -$7.44M | -$4.66M | -$2.17M | -$2.34M | -$235K |
| Basic EPS | -- | -- | -- | -- | -- | -$75,687.84 | -$238,416.71 | -$189,219.61 | -$348,164.08 | -$5,676.59 |
| **Diluted EPS** | -$395,154.12 | -$577,581.51 | -$594,149.57 | -- | -- | -$75,687.84 | -$238,416.71 | -$276,260.63 | -$348,164.08 | -$5,676.59 |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | 98.7K | 19.6K | 11 | 7 | 46 |
| Diluted Shares Outstanding | 33 | 17 | 16 | -- | -- | 98.7K | 19.6K | 11 | 7 | 10 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $803K | $876K | $773K | $893K | $1.27M | $1.87M | $1.38M | $2.48M |
| Total Operating Expenses | $1.79M | $2.50M | $2.69M | $2.79M | $3.09M | $3.15M | $2.38M | $3.81M |
| **Operating Income** | -$1.79M | -$2.50M | -$2.69M | -$2.79M | -$3.09M | -$3.15M | -$2.38M | -$3.81M |
| Interest Income | $24K | $42K | $1.0K | -- | $5.0K | $1.0K | $7.0K | -- |
| Interest Expense | $0 | $6.0K | $100K | $11K | $111K | $72K | $0 | -- |
| Income Tax Expense | -- | $0 | -- | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$1.77M | -$2.43M | -$2.96M | -$4.17M | -$3.12M | -$3.22M | -$2.37M | -$3.78M |
| **Diluted EPS** | -$3.19 | -$539.33 | -$7,271.85 | -- | -$88.80 | -$10,216.94 | -$22,815.42 | -- |
| Diluted Shares Outstanding | 554.2K | 4.5K | 406 | -- | 35.1K | 315 | 104 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $600K | -- | -- | $6.89M | $12.16M | $6.63M | $2.14M | $4.42M | $337K | $573K |
| Short-Term Investments | -- | $0 | $7.61M | $9.15M | $11.95M | $3.44M | $0 | -- | -- | -- |
| **Cash & Short-Term Investments** | $600K | -- | -- | $16.04M | $24.11M | $10.06M | $2.14M | $4.42M | $337K | $573K |
| **Total Current Assets** | $695K | $2.56M | $10.98M | $18.32M | $24.61M | $10.32M | $2.34M | $4.44M | $396K | $574K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $246 | $721 | $563 | -- |
| Intangible Assets | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | -- | -- |
| Long-Term Investments | -- | $0 | $7.61M | $9.15M | $11.95M | $3.44M | -- | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | $3.0K | $3.0K | $189K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $2.11M | $2.14M | $2.06M | $2.10M | $3.64M | $2.32M | $2.04M | $2.04M | $563 | $0 |
| **Total Assets** | $2.80M | $4.70M | $13.04M | $20.42M | $28.25M | $12.63M | $4.38M | $6.48M | $397K | $574K |
| Accounts Payable | -- | -- | -- | -- | -- | -- | -- | $639K | -- | -- |
| **Total Current Liabilities** | $4.04M | $1.77M | $1.29M | $998K | $1.03M | $526K | $501K | $1.02M | $532K | $29K |
| **Total Non-Current Liabilities** | $29K | $69K | $0 | $23K | $57K | $67K | $0 | $1.2K | $0 | $0 |
| **Total Liabilities** | $4.07M | $1.84M | $1.29M | $1.02M | $1.08M | $593K | $501K | $1.02M | $532K | $29K |
| **Total Debt (incl. Leases)** | $69K | $104K | -- | $23K | $57K | $67K | -- | -- | -- | -- |
| Common Stock | $0 | $1.0K | $3.0K | $3.0K | $3.0K | $2.0K | $5.0K | $3.4K | $1.8K | $11K |
| Retained Earnings | -$63.02M | -$50.14M | -$40.31M | -$31.02M | -$20.94M | -$16.90M | -$9.47M | -$4.81M | -$2.64M | -$295K |
| Accumulated Other Comp. Income | -$272K | -$202K | -$203K | -$254K | -$18K | $18K | $64K | -$9.8K | -$12K | $657 |
| **Total Stockholders' Equity** | -$1.27M | $2.86M | $11.75M | $19.40M | $27.17M | $12.04M | $3.88M | $5.46M | -$135K | $545K |
| Total Equity | -$1.27M | $2.86M | $11.75M | $19.40M | $27.17M | $12.04M | $3.88M | $5.46M | -$135K | $545K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.2K | -- | $4.20M | $600K | -- | -- | -- | -- |
| Short-Term Investments | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | $4.2K | -- | $4.20M | $600K | -- | -- | -- | -- |
| **Total Current Assets** | $4.60M | $4.37M | $10.42M | $695K | $1.83M | $2.23M | $1.38M | $2.56M |
| Intangible Assets | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $2.08M | $2.09M | $2.10M | $2.11M | $2.44M | $2.12M | $2.13M | $2.14M |
| **Total Assets** | $6.67M | $6.46M | $12.52M | $2.80M | $4.27M | $4.36M | $3.52M | $4.70M |
| **Total Current Liabilities** | $439K | $1.46M | $5.83M | $4.04M | $4.86M | $5.71M | $2.80M | $1.77M |
| **Total Non-Current Liabilities** | $0 | $7.0K | $18K | $29K | $40K | $51K | $59K | $69K |
| **Total Liabilities** | $439K | $1.46M | $5.85M | $4.07M | $4.90M | $5.76M | $2.86M | $1.84M |
| **Total Debt (incl. Leases)** | $40K | $49K | $59K | $69K | $79K | $87K | $95K | $104K |
| Common Stock | $1.0K | $4.0K | $1.0K | $0 | $2.0K | $1.0K | $3.0K | $1.0K |
| Retained Earnings | -$70.17M | -$68.40M | -$65.97M | -$63.02M | -$58.85M | -$55.73M | -$52.51M | -$50.14M |
| Accumulated Other Comp. Income | -$242K | -$242K | -$246K | -$272K | -$277K | -$295K | -$227K | -$202K |
| **Total Stockholders' Equity** | $6.24M | $5.00M | $6.67M | -$1.27M | -$635K | -$1.41M | $651K | $2.86M |
| Total Equity | $6.24M | $5.00M | $6.67M | -$1.27M | -$635K | -$1.41M | $651K | $2.86M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.88M | -$9.83M | -$9.29M | $10.08M | -$9.41M | $7.44M | -$4.66M | -$2.17M | -$2.34M | -$235K |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | $500 | $510 | $282 | -- |
| Stock-Based Compensation | $1.14M | $818K | $1.02M | $2.46M | -- | $1.53M | $381K | $425K | $290K | $3.3K |
| **Operating Cash Flow** | -$8.52M | -$8.35M | -$8.21M | -$8.01M | -- | -$6.14M | -$4.35M | -$2.79M | -$1.61M | -$217K |
| Purchases of Investments | $0 | -$481K | $0 | -$499K | -- | $0 | -- | -- | -- | -- |
| **Investing Cash Flow** | -$62K | $7.77M | $3.51M | $2.96M | -- | -$3.44M | $0 | -$1.50M | -$845 | -- |
| Common Stock Issued | $6.15M | $112K | $567K | $0 | -- | $8.10M | $1.98M | $8.38M | $1.39M | $773K |
| **Financing Cash Flow** | $6.87M | $112K | $567K | $0 | -- | $14.11M | $1.98M | $8.38M | $1.39M | $785K |
| **Net Change in Cash** | -$1.74M | -$477K | -$4.07M | -$5.27M | -- | $4.49M | -$2.28M | $4.09M | -$235K | $569K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.77M | -$2.43M | -$2.96M | -$4.17M | -$3.12M | -$3.22M | -$2.37M | -$15.87M |
| Stock-Based Compensation | -$354K | $570K | $401K | $368K | $432K | $150K | $192K | $201K |
| **Operating Cash Flow** | -$2.62M | -$5.03M | -$1.19M | -$2.91M | -$3.50M | -$514K | -$1.60M | -$2.57M |
| Purchases of Investments | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Investing Cash Flow** | -- | -- | -- | $188K | -$250K | $0 | $0 | $500K |
| Common Stock Issued | $2.86M | $175K | $10.03M | $1.76M | $3.31M | $1.08M | $0 | $57K |
| **Financing Cash Flow** | $2.86M | -$1.06M | $10.86M | $1.61M | $3.44M | $1.82M | $0 | $57K |
| **Net Change in Cash** | $239K | -$6.08M | $9.67M | -$1.12M | -$346K | $1.32M | -$1.59M | -$2.02M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -344.0% | -79.0% | -52.0% | -34.6% | -61.8% | -120.1% | -39.8% | -- | -43.1% |
| Return on Assets (ROA) | -459.8% | -209.2% | -71.2% | -49.4% | -33.3% | -58.9% | -106.4% | -33.5% | -590.3% | -40.9% |
| Current Ratio | 0.17x | 1.44x | 8.51x | 18.36x | 23.96x | 19.61x | 4.66x | 4.35x | 0.75x | 19.51x |
| Quick Ratio | 0.15x | -- | -- | 16.07x | 23.48x | 19.13x | 4.28x | 4.33x | 0.63x | 19.46x |
| Debt to Equity | -- | 0.04x | -- | 0.00x | 0.00x | 0.01x | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -181.5% | -253.6% | -201.8% | -- | -- | -- | -1492.3% | -344.0% |
| Return on Assets (ROA) | -169.6% | -196.2% | -107.6% | -459.8% | -292.7% | -241.1% | -276.4% | -209.2% |
| Current Ratio | 10.47x | 3.00x | 1.79x | 0.17x | 0.38x | 0.39x | 0.49x | 1.44x |
| Quick Ratio | 0.01x | -- | 0.72x | 0.15x | -- | -- | -- | -- |
| Debt to Equity | 0.01x | 0.01x | 0.01x | -- | -- | -- | 0.15x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
